Boston Scientific to Acquire Asthmatx – Zacks.com


Daily Rosetta

Boston Scientific to Acquire Asthmatx
Zacks.com
Asthmatx is focused on the development of less-invasive, catheter-based bronchial thermoplasty procedure, meant to treat severe persistent asthma patients
Investor group to sell Asthmatx to Boston ScientificTrading Markets (press release)
Boston Scientific to Buy Asthmatx for $193.5 Million Gaining Asthma DeviceBloomberg
Boston Scientific Pays $444M For AsthmatxEmii.com
Reuters –FOXBusiness –Wall Street Journal
all 133 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *